Anesiva Inc

Summary

Introduction

Anesiva (previously Corgentech), based in South San Francisco, California, is a late stage biotechnology company with two product candidates: Zingo and Altea for the potential treatment of various pain management indications. The company merged with AlgoRX, a privately-held pain management company, to expand its pipeline portfolio.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Anesiva is focused on developing and commercializing novel treatments for pain management. It is preparing to launch Zingo, its approved product, through its sales force and co-promoter in the US. Altea, its second product candidate in Phase II, is being studied for the treatment of post surgery pain management. Anesiva recognized revenues as collaboration payments and license fees from Bristol Meyers Squibb and Lumen Therapeutics. Its total revenues declined from $0.15 million in 2002 to $0.09 million in 2006. Moreover, it did not record revenues in 2004 and 2005. Anesiva expects to generate all of its revenues during 2006-2010 from sales of Zingo. The product is forecasted to contribute $114 million by 2010 to the company's coffers.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Contents

• Overview
• Catalyst
• Summary
  • Company Structure
  • Company Overview and Key Facts
  • Business Description
  • History
  • Locations and Subsidiaries
  • Company Financials
  • Stock Market Performance
  • P&l
  • Balance Sheet
  • Cash Flow
  • Business Segment Performance
  • Products & Services
  • Pipeline Products
  • Ac Forecast Product Sales
  • Competitors and Strategic Business Relationships
  • Key Competitors
  • Key Suppliers
  • Key Clients
  • Shareholding Structure
  • Strategy
  • Company View
  • Corporate Strategy
  • SWOT Analysis
  • Overview
  • Strengths
  • Weaknesses
  • Opportunities
  • Threats
  • Value Chain Analysis
  • Overview
  • Discovery and Product Development
  • Manufacturing
  • Sales
  • Scorecard
  • Overview
  • Scorecard Analysis
  • Key Employees
  • List of Key Employees
  • Key Employee Biographies
  • Financial and Operational Overview
  • Financial and Operational Overview
  • Appendix
  • Ask The Analyst
  • Datamonitor Consulting
  • Disclaimer
• Table of Figures
  • Figure 1: Anesiva- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
• Table of Tables
  • Table 1: Anesiva- Key Facts
  • Table 2: Anesiva- Locations and Subsidiaries
  • Table 3: Anesiva- Year-End Share Price and Market Capitalization, 2002-2006 ($)
  • Table 4: Anesiva- Key Events Impacting Share Price Performance
  • Table 5: Anesiva- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
  • Table 6: Anesiva- Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
  • Table 7: Anesiva- Balance Sheet, 2002-2006 ($ Mn)
  • Table 8: Anesiva- Cash Flow, 2002-2006 ($ Mn)
  • Table 9: Anesiva- Key Strategic Revenues, 2002-2006 ($ Mn)
  • Table 10: Anesiva- in-House Pipeline Products
  • Table 11: Anesiva- Key Strategic Revenues, 2006-2010 ($ Mn)
  • Table 12: Anesiva- Key Competitors
  • Table 13: Anesiva- Key Suppliers
  • Table 14: Anesiva- Key Clients
  • Table 15: Anesiva- Key Shareholders
  • Table 16: Anesiva - SWOT Analysis Summary
  • Table 17: Anesiva- Value Chain Analysis
  • Table 18: Anesiva- Scorecard
  • Table 19: Anesiva- Key Employees
  • Table 20: Anesiva- Financial and Operational Overview